Correlation Between Annexon and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Annexon and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Immix Biopharma, you can compare the effects of market volatilities on Annexon and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Immix Biopharma.
Diversification Opportunities for Annexon and Immix Biopharma
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Annexon and Immix is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Annexon i.e., Annexon and Immix Biopharma go up and down completely randomly.
Pair Corralation between Annexon and Immix Biopharma
Given the investment horizon of 90 days Annexon is expected to under-perform the Immix Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Annexon is 1.05 times less risky than Immix Biopharma. The stock trades about -0.42 of its potential returns per unit of risk. The Immix Biopharma is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest 220.00 in Immix Biopharma on November 2, 2024 and sell it today you would lose (23.00) from holding Immix Biopharma or give up 10.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Annexon vs. Immix Biopharma
Performance |
| Timeline |
| Annexon |
| Immix Biopharma |
Annexon and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annexon and Immix Biopharma
The main advantage of trading using opposite Annexon and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Annexon vs. Immix Biopharma | Annexon vs. Cns Pharmaceuticals | Annexon vs. Hepion Pharmaceuticals | Annexon vs. Day One Biopharmaceuticals |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |